SCTREX Trademark

Trademark Overview


On Tuesday, August 13, 2019, a trademark application was filed for SCTREX with the United States Patent and Trademark Office. The USPTO has given the SCTREX trademark a serial number of 88576447. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 21, 2020. This trademark is owned by Cumberland Pharmaceuticals Inc.. The SCTREX trademark is filed in the Pharmaceutical Products category with the following description:

Anti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including arthritis, juvenile idiopathic arth...
sctrex

General Information


Serial Number88576447
Word MarkSCTREX
Filing DateTuesday, August 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 21, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements


Goods and ServicesAnti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events


Event DateEvent Description
Monday, September 21, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 21, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2019ASSIGNED TO EXAMINER
Wednesday, August 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 16, 2019NEW APPLICATION ENTERED IN TRAM